[1] Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer[J]. Biochim Biophys Acta, 2007, 1775(1):21-62.
[2] Massague J, Gomis RR. The logic of TGFbeta signaling[J]. FEBS Lett, 2006, 580(12):2811-2820.
[3] Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus[J]. Cell, 2003, 113(6):685-700.
[4] Schmierer B, Hill CS. TGFbeta-SMAD signal transduction:molecular specificity and functional flexibility[J]. Nat Rev Mol Cell Biol, 2007, 8(12):970-982.
[5] Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling[J]. FASEB J, 1999, 13(15):2105-2124.
[6] Harrison CA, Gray PC, Vale WW, et al. Antagonists of activin signaling:mechanisms and potential biological applications[J]. Trends Endocrinol Metab, 2005, 16(2):73-78.
[7] Christian M, Cermak T, Doyle EL, et al. Targeting DNA double-strand breaks with TAL effector nucleases[J]. Genetics, 2010, 186(2):757-761.
[8] Shen Y, Xiao A, Huang P, et al. TALE nuclease engineering and targeted genome modification[J]. Yi Chuan, 2013, 35(4):395-409.
[9] Bogdanove AJ, Schornack S, Lahaye T. TAL effectors:finding plant genes for disease and defense[J]. Curr Opin Plant Biol, 2010, 13(4):394-401.
[10] Yang B, Sugio A, White FF. Avoidance of host recognition by alterations in the repetitive and C-terminal regions of AvrXa7, a type III effector of Xanthomonas oryzae pv. oryzae[J]. Mol Plant Microbe Interact, 2005, 18(2):142-149.
[11] Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type III effectors[J]. Science, 2009, 326(5959):1509-1512.
[12] Moscou MJ, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors[J]. Science, 2009, 326(5959):1501.
[13] Cermak T, Doyle EL, Christian M, et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting[J]. Nucleic Acids Res, 2011, 39(12):e82.
[14] Huang P, Xiao A, Zhou M, et al. Heritable gene targeting in zebrafish using customized TALENs[J]. Nat Biotechnol, 2011, 29(8):699-700.
[15] 梁龙, 皮文辉. TAL 效应子应用研究进展[J].生物技术通报, 2012(11):54-59.
[16] Weber E, Gruetzner R, Werner S, et al. Assembly of designer TAL effectors by Golden Gate cloning[J]. PLoS One, 2011, 6(5):e19722.
[17] Li T, Huang S, Zhao X, et al. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes[J]. Nucleic Acids Res, 2011, 39(14):6315-6325.
[18] Zhang F, Cong L, Lodato S, et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription[J]. Nat Biotechnol, 2011, 29(2):149-153.
[19] Shen Y, Huang P, Zhang B. A protocol for TALEN construction and gene targeting in zebrafish[J]. Yi Chuan, 2013, 35(4):533-544.
[20] Gu Z, Nomura M, Simpson BB, et al. The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse[J]. Genes Dev, 1998, 12(6):844-857.
|